Advanced wound care, made personal

A lightweight device, that fits seamlessly into standard of care A lightweight device, that fits seamlessly into standard of care
Swiss Medical Technology

A lightweight device, that fits seamlessly into standard of care

Get to know our product

The benefits of COMS®-Technology*

Treatment of chronic wounds represents a challenge for both the patient and modern healthcare systems

How it works
Accelerated Wound Closure

Accelerated Wound Closure

To produce a durable closure for hard-to-heal wounds.

Ease of Use

Ease of Use

Treatment is non-invasive and requires minimal staff supervision.

Decreased Costs

Decreased Costs

Healing of chronic wounds significantly decreases the financial burden of modern health care.

Platform Technology

Platform Technology

The underlying mechanism of action can be applied to different pathological conditions.


*The COMS® One therapy system is not cleared in the US.

Who are we?

Who are we?

We are a young company founded and based in Zurich, Switzerland since 2016. The Piomic family consists of biologists, engineers, entrepreneurs, designers, seniors and a broad group of supporters. Staffed with experts from different backgrounds and a common goal: By developing a therapy which is safe and effective, we want to set a better future for patients in need.

More about us

Do you want to contribute to our vision?

Do you want to contribute to our vision?

In order to maximize our global impact, we are looking for investors who share our vision and wish to shape the future of wound care with us.

Information for investors

Latest news

Piomic receives certification under MDR, the new European Medical Device Regulation

27 Apr 2023

Piomic Medical has received certificates according to MDR for its Class IIa and Class Is medical devices of the COMS® One Therapy System.

Read more
Piomic receives certification under MDR, the new European Medical Device Regulation
Bernard Laurel appointed as the President of Piomic Medical Inc.

10 Feb 2023

M&A experienced advanced wound care leader appointed as President of US Subsidiary Piomic Medical Inc.

Read more
Bernard Laurel appointed as the President of Piomic Medical Inc.
Piomic Medical receives unconditional FDA IDE approval for U.S. pivotal trial

01 Dec 2022

Piomic Medical receives unconditional IDE approval from the FDA for MAVERICKS, the pivotal study for the COMS® One Therapy System in patients with refractory diabetic foot ulcers.

Read more
Piomic Medical receives unconditional FDA IDE approval for U.S. pivotal trial
Bertrand Hughes appointed as the Chairman of the Board of Directors

05 Aug 2022

Highly experienced expert in advanced wound care appointed Chairman of the Board of Directors.

Read more
Bertrand Hughes appointed as the Chairman of the Board of Directors
Don't miss our updates!
You must complete your email.
You must accept our Privacy Policy

Our Partners

Do you want to cooperate with us?

We are constantly trying to expand our interdisciplinary know-how and increase the impact of our novel technology on the lives of patients. Therefore we are looking to conncet to the brightest minds in their field of expertise and share our knowledge to create easy-to-use products and innovative wound care solutions.